CAM
OLMA icon

ClariVest Asset Management’s Olema Pharmaceuticals OLMA Stock Holding History

ClariVest Asset Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$683K Hold
63,149
– – 0.07% 322
2024
Q2 		$683K Buy
63,149
+1,881
+3% +$20.4K 0.07% 322
2024
Q1 		$694K Sell
61,268
-6,200
-9% -$80K 0.07% 332
2023
Q4 		$947K Buy
67,468
+1,568
+2% +$21.1K 0.05% 268
2023
Q3 		$813K Buy
65,900
+12,700
+24% +$129K 0.04% 274
2023
Q2 		$481K Buy
+53,200
New +$321K 0.02% 349

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

ClariVest Asset Management's OLMA Position: Q3 2024 in Review

ClariVest Asset Management held its Olema Pharmaceuticals (OLMA) position steady in Q3 2024 at 63,149 shares worth $683K. The position accounts for 0.07% of the portfolio, ranked #322.

ClariVest Asset Management first reported a position in OLMA in Q2 2023 and has held it in 6 quarters since. The position peaked at $947K in Q4 2023. 130 funds tracked by Wall St. Rank hold OLMA as of Q3 2024.

  • ClariVest Asset Management held 63,149 shares of Olema Pharmaceuticals worth $683K as of Q3 2024.
  • ClariVest Asset Management left its Olema Pharmaceuticals share count unchanged in Q3 2024.
  • Olema Pharmaceuticals made up 0.07% of ClariVest Asset Management's portfolio in Q3 2024, its #322 holding.
  • ClariVest Asset Management first reported a position in Olema Pharmaceuticals in Q2 2023 and has held it in 6 quarters since.
  • ClariVest Asset Management's Olema Pharmaceuticals position peaked at $947K in Q4 2023.
  • 130 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.